5087.5000 -50.50 (-0.98%)
NSE Sep 11, 2026 15:31 PM
Volume: 238.8K
 

5087.50
-0.98%
ICICI Securities Limited
Alkem Laboratories’ CEO, Dr. Vikas Gupta, is targeting double-digit revenue growth in the medium term, driven by strong hold in India (68% of sales), other international markets and new ventures.
Alkem Laboratories Ltd. is trading below all available SMAs
More from Alkem Laboratories Ltd.
Recommended